Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mid-molecule parathyroid hormone assay comparison.

W M Ivie, E S Orwoll, M R McClung

    Clinical Biochemistry
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
    Same author

    Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis.

    Archives of osteoporosis·2023
    Same author

    Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
    Same author

    Osteoanabolic therapy for osteoporosis in women.

    Climacteric : the journal of the International Menopause Society·2021
    Same author

    Sleep duration and bone health measures in older men.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
    Same author

    A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
    Same journal

    Analytical outlier rates for Roche fifth generation cardiac troponin T stat using biotin sensitive and insensitive reagent lots.

    Clinical biochemistry·2026
    Same journal

    Evaluation of hemoglobin interference thresholds for chemical urinalysis panels.

    Clinical biochemistry·2026
    Same journal

    Integrated genomic and biochemical diagnosis of a novel homozygous start-loss variant in AKR1D1 associated with neonatal cholestasis.

    Clinical biochemistry·2026
    Same journal

    Agreement between POC glucose meters and blood gas analyzers varies across ICU patient populations.

    Clinical biochemistry·2026
    Same journal

    From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

    Clinical biochemistry·2026
    Same journal

    Response to the letter to the editor: From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

    Clinical biochemistry·2026
    See all related articles

    Two new parathyroid hormone (PTH) assays show clinical utility for in-house laboratory use. These assays effectively differentiate normal from abnormal PTH-calcium homeostasis in various endocrine conditions.

    Area of Science:

    • Clinical Chemistry
    • Endocrinology
    • Assay Development

    Background:

    • Parathyroid hormone (PTH) assays are increasingly accessible for clinical chemistry laboratories.
    • Evaluating the clinical utility of new PTH assays is crucial for accurate patient diagnosis.

    Purpose of the Study:

    • To assess the clinical utility of two mid-molecule PTH assays for in-house laboratory use.
    • To compare these assays against a technically demanding component assay.

    Main Methods:

    • Evaluated two mid-molecule PTH assays (EMC and INC kits) against a component assay.
    • Tested a reference population and abnormal patient groups (hyperparathyroidism, hypoparathyroidism, malignancy).
    • Measured PTH and total serum calcium levels for all specimens.

    Related Experiment Videos

    Main Results:

    • Both EMC and INC assays demonstrated adequate reproducibility and precision for clinical use.
    • Assays, aided by calcium levels, effectively separated abnormal patient groups and normal from abnormal PTH-calcium homeostasis.
    • Reference population PTH values varied across the three assays.

    Conclusions:

    • The evaluated mid-molecule PTH assays possess clinical utility for in-house laboratory use.
    • These assays, when combined with calcium measurements, aid in distinguishing various endocrine disorders.
    • Differences in PTH values and correlations with serum calcium were observed between the assays.